Overview

Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours

Status:
Completed
Trial end date:
2019-01-16
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the best dose of vinblastine that can be given with a new drug, temsirolimus.
Phase:
Phase 1
Details
Lead Sponsor:
Canadian Cancer Trials Group
Collaborator:
Pfizer
Treatments:
Everolimus
Sirolimus
Vinblastine